
Nitin Bhayana
About Nitin Bhayana
Data last updated:
Nitin Bhayana is a Director at Syndicate Life Sciences Private Limited (since 2010), Director at Aricate Formulations Private Limited (since 2018) and Designated Partner at Elavitra Labs Llp (since 2018). The companies operate in Pharma and Information Technology. The largest current company by reported revenue is Syndicate Life Sciences Private Limited at ₹16.12 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Feb 2010 | 2010 | ₹16.12 Cr (FY 2025) | Active | |
| Director | 12 Dec 2018 | 2018 | Active | ||
| Designated Partner | 04 Dec 2018 | 2018 | Active |
Board colleagues of Nitin Bhayana
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sagar Uppal | 02883026 | Syndicate Life Sciences Private Limited , Elavitra Labs Llp | Director |
| Umesh Kalra | 01341902 | Aricate Formulations Private Limited | Director |
| Madhuri Dubey | 08214336 | Elavitra Labs Llp | Designated Partner |
| Pragya Srivastava | 08214574 | Elavitra Labs Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nitin Bhayana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nitin Bhayana
Nitin Bhayana currently holds 3 directorships: Syndicate Life Sciences Private Limited (Director, since 15 Feb 2010, revenue ₹16.12 Cr (FY 2025)); Aricate Formulations Private Limited (Director, since 12 Dec 2018); Elavitra Labs Llp (Designated Partner, since 04 Dec 2018).
Nitin Bhayana was first appointed on 15 Feb 2010 as Director at Syndicate Life Sciences Private Limited. The most recent appointment on record is 12 Dec 2018 at Aricate Formulations Private Limited.
The current boards of Nitin Bhayana's companies include Sagar Uppal (Syndicate Life Sciences Private Limited), Umesh Kalra (Aricate Formulations Private Limited), Madhuri Dubey (Elavitra Labs Llp), Pragya Srivastava (Elavitra Labs Llp).